Want to join the conversation?
In FY16, $GPS expects FX rate fluctuations to negatively impact its results, particularly in its foreign subsidiaries in Canada and Japan. $GPS expects net sales translated into US dollars to negatively impact total net sales growth. GM for foreign subsidiaries is expected to be negatively impacted as $GPS' merchandise purchases are in US dollars.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.